Subscribe for full access
Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
N/A
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
Total Analysts: 0
Company Profile
Vivo Bio Tech Limited is an India-based full service pre-clinical clinical research organization (CRO). The Company offers drug development and discovery services to pharmaceutical and biotech companies across the world. The Company offers services in the areas of In vivo and In vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, genotoxicity screening, analytical services, and other. It provides both regulatory and non-regulatory IND enabling preclinical development services. It is engaged in screening and evaluating molecules for various pharmacological and therapeutic properties. Specifically for oncology, the Company provides designing and development of syngeneic/xenograft models for evaluation of anti-cancer agents. The Company also customizes In vivo drug metabolism and pharmacokinetics (DMPK) studies to help profile drug candidate in both rodent and non-rodent animal models.Vivo Bio Tech Limited is an India-based full service pre-clinical clinical research organization (CRO). The Company offers drug development and discovery services to pharmaceutical and biotech companies across the world. The Company offers services in the areas of In vivo and In vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, genotoxicity screening, analytical services, and other. It provides both regulatory and non-regulatory IND enabling preclinical development services. It is engaged in screening and evaluating molecules for various pharmacological and therapeutic properties. Specifically for oncology, the Company provides designing and development of syngeneic/xenograft models for evaluation of anti-cancer agents. The Company also customizes In vivo drug metabolism and pharmacokinetics (DMPK) studies to help profile drug candidate in both rodent and non-rodent animal models.
We do our best to screen stocks as accurately as possible. Please let us know in the Community if you spot an error or find something questionable. Jazaak Allahu khairan.
